Rainbow Childrens Medicare enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
11,882————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
43843859131873.5
15.515.56.86.05.0
11,460————
−438−438−591−318−73.5
₹1,128.36————
1,6641,6641,4751,2651,065
6.30×————
19.92×————
27.51×————
56.40×————
Reference items — trailing FY values
1,8201,7031,5161,2971,174
575544490429396
417394351317306
—420396321327
203203250−32.2186
—187231−47.5185
—216146354141
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RAINBOW₹1,170.00

Rainbow Childrens Medicare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISKIMSPOLYMEDPFIZERONESOURCEJUBLPHARMAVIJAYAMcap ₹11,882 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————11,882.4
- Cash, Equiv & ST Investments73.5317.6591.0438.4438.4
+ Minority Interest5.06.06.815.515.5
Enterprise Value————11,459.5
Net Debt (memo)-73.5-317.6-591.0-438.4-438.4
EV per Share————1,128.36
Total Capital1,064.91,264.91,475.01,663.61,663.6
EV/Sales————6.30
EV/EBITDA————19.92
EV/EBIT————27.51
EV/Free Cash Flow————56.40
Reference Items — Trailing FY Values
Sales1,173.61,296.91,515.91,703.11,820.1
EBITDA396.4428.9489.9544.2575.2
EBIT306.1316.8351.4393.6416.6
Operating Cash Flow327.2321.4395.7419.7—
Free Cash Flow185.9-32.2250.0203.2203.2
FCFF (free cash flow to the firm)185.1-47.5231.2186.6—
Capital Expenditure141.3353.6145.7216.5—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.